Metoject subcutaneous injection 7.5mg syringe 0.15mL

Metoject subcutaneous injection 7.5mg syringe 0.15mL, manufactured by Japan Medac, contains methotrexate. Methotrexate is an antimetabolite and immunosuppressant used to treat various cancers, autoimmune diseases like rheumatoid arthritis, juvenile idiopathic arthritis, and severe psoriasis. It works by inhibiting enzymes involved in nucleotide synthesis and modulating immune function. It is supplied as a 7.5mg/0.15mL/1 tube injectable drug (YJ code: 3999468G1028).